Generation Bio(GBIO) - 2024 Q1 - Quarterly Results

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results CAMBRIDGE, MASS., May 13, 2024 -- Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported additional data on its cell-targeted lipid nanoparticle (ctLNP) platform presented at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting as well as first quarter 2024 financial results. "The data presented on our ...